Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2006

01-08-2006 | Concise Article

Changing trends in etiology of bacteremia in patients with cancer

Authors: A. Safdar, G. H. Rodriguez, M. Balakrishnan, J. J. Tarrand, K. V. I. Rolston

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2006

Login to get access

Abstract

The present study was conducted to determine trends in the quantitative bacterial load patterns of bacterial bloodstream infections (BSI) caused by various bacteria in patients receiving care at a comprehensive cancer center. Bacterial loads of all consecutive quantitative blood cultures performed during 1998 and 2004 were graded quantitatively. Gram-positive bacteria (GPB) were responsible for the majority of BSI episodes in both years studied: 740 of 1,055 (73%) in 1998 and 820 of 1,025 (82%) in 2004. Compared with GPB infections, a significant proportion of infections caused by Gram-negative bacteria was associated with a high bacterial load (HBL) (11 vs 28% in 1998 and 10 vs 30% in 2004; p<0.001). In 2004, BSI episodes due to non-Pseudomonas non-fermentative GNB (Stenotrophomonas maltophilia and Acinetobacter spp) were significantly associated with a HBL compared to BSI due to Pseudomonas aeruginosa (47 vs 23%; p<0.05); this was not the case in 1998. Conversely, the HBLs commonly associated with BSI due to Staphylococcus aureus (50%) and Streptococcus spp (35%) versus coagulase-negative staphylococci (13%; p<0.0001) during 1998 were not noted during 2004 (22% Staphylococcus aureus, 20% Streptococcus spp, 21% coagulase-negative staphylococci; p>0.5). The spectrum of BSI continues to change and its prognostic implications in cancer patients needs further study.
Literature
1.
go back to reference Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Critical Care Clin 17:531–570CrossRef Safdar A, Armstrong D (2001) Infectious morbidity in critically ill patients with cancer. Critical Care Clin 17:531–570CrossRef
2.
go back to reference Rolston KV (2004) The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 39(Suppl 1):44–48CrossRef Rolston KV (2004) The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin Infect Dis 39(Suppl 1):44–48CrossRef
3.
go back to reference Chatzinikalaou I, Abi-Said D, Bodey GP, Rolston KVI, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Arch Intern Med 160:501–509CrossRef Chatzinikalaou I, Abi-Said D, Bodey GP, Rolston KVI, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Arch Intern Med 160:501–509CrossRef
4.
go back to reference Rolston KVI, Tarrand JJ (1999) Pseudomonas aeruginosa—still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 29:463–464PubMedCrossRef Rolston KVI, Tarrand JJ (1999) Pseudomonas aeruginosa—still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 29:463–464PubMedCrossRef
5.
go back to reference Douard MC, Arlet G, Leverger G, Paulien R, Waintrop C, Clementi E, Eurin B, Schaison G (1991) Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 17:30–35PubMedCrossRef Douard MC, Arlet G, Leverger G, Paulien R, Waintrop C, Clementi E, Eurin B, Schaison G (1991) Quantitative blood cultures for diagnosis and management of catheter-related sepsis in pediatric hematology and oncology patients. Intensive Care Med 17:30–35PubMedCrossRef
6.
go back to reference Germanakis J, Stiakaki E, Galanakis E, Christidou A, Neonakis J, Dimitriou H, Tselentis Y, Kalmanti M (2002) Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 34:680–682PubMedCrossRef Germanakis J, Stiakaki E, Galanakis E, Christidou A, Neonakis J, Dimitriou H, Tselentis Y, Kalmanti M (2002) Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children. Scand J Infect Dis 34:680–682PubMedCrossRef
7.
go back to reference Safdar A, Raad II (2004) Management and treatment. In: O’Grady N, Pittet D (eds) Catheter-related infections in the critically ill. Kluwer, Boston, pp 99–112CrossRef Safdar A, Raad II (2004) Management and treatment. In: O’Grady N, Pittet D (eds) Catheter-related infections in the critically ill. Kluwer, Boston, pp 99–112CrossRef
8.
go back to reference Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR (1986) Activity of penicillin combined with an aminoglycoside against group B Streptococcus in vitro and in experimental endocarditis. J Antimicrob Chemother 18:491–498PubMedCrossRef Backes RJ, Rouse MS, Henry NK, Geraci JE, Wilson WR (1986) Activity of penicillin combined with an aminoglycoside against group B Streptococcus in vitro and in experimental endocarditis. J Antimicrob Chemother 18:491–498PubMedCrossRef
9.
go back to reference Baddour LM, Christensen GD, Bisno AL (1987) Bacterial concentration correlates in experimental endocarditis caused by Staphylococcus epidermidis. J Clin Microbiol 25:207–210PubMed Baddour LM, Christensen GD, Bisno AL (1987) Bacterial concentration correlates in experimental endocarditis caused by Staphylococcus epidermidis. J Clin Microbiol 25:207–210PubMed
10.
go back to reference Enzler MJ, Rouse MS, Henry NK, Wilson WR (1987) In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis 155:954–958PubMed Enzler MJ, Rouse MS, Henry NK, Wilson WR (1987) In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis 155:954–958PubMed
11.
go back to reference Garrison PK, Freedman LR (1970) Experimental endocarditis: I. Staphylococcus endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med 42:394–410PubMed Garrison PK, Freedman LR (1970) Experimental endocarditis: I. Staphylococcus endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med 42:394–410PubMed
12.
go back to reference Yuste J, Jado I, Gimenez MJ, Aguilar L, Molero F, Fenoll A, Casal J (2002) Modification of bacteremia by specific antibodies and relation with mortality in pneumococcal mouse sepsis model. Clin Exp Immunol 128:411–415PubMedCrossRef Yuste J, Jado I, Gimenez MJ, Aguilar L, Molero F, Fenoll A, Casal J (2002) Modification of bacteremia by specific antibodies and relation with mortality in pneumococcal mouse sepsis model. Clin Exp Immunol 128:411–415PubMedCrossRef
13.
go back to reference Whimbey E, Kiehn TE, Brannon P, Benezra D, Armstrong D (1987) Clinical significance of colony counts in immunosuppressed patients with Staphylococcus aureus bacteremia. J Infect Dis 155:1328–1330PubMed Whimbey E, Kiehn TE, Brannon P, Benezra D, Armstrong D (1987) Clinical significance of colony counts in immunosuppressed patients with Staphylococcus aureus bacteremia. J Infect Dis 155:1328–1330PubMed
14.
go back to reference Schonheyder HC, Gottschau A, Friland A, Rosdahl VT (1995) Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis 27:19–21PubMedCrossRef Schonheyder HC, Gottschau A, Friland A, Rosdahl VT (1995) Mortality rate and magnitude of Staphylococcus aureus bacteremia as assessed by a semiquantitative blood culture system. Scand J Infect Dis 27:19–21PubMedCrossRef
15.
go back to reference Elting LS, Rubenstein EB, Rolston KVI, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMedCrossRef Elting LS, Rubenstein EB, Rolston KVI, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMedCrossRef
16.
go back to reference Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV (1991) Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 29:2245–2249PubMed Tarrand JJ, Guillot C, Wenglar M, Jackson J, Lajeunesse JD, Rolston KV (1991) Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems. J Clin Microbiol 29:2245–2249PubMed
17.
go back to reference Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706–718PubMedCrossRef Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M (2003) Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 188:706–718PubMedCrossRef
18.
go back to reference Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ (1995) Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21:1498–1500PubMed Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DA, Angus B, White NJ (1995) Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 21:1498–1500PubMed
19.
go back to reference Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, Lopez MJ, Soriano A, Horacajada JP, Gatell JM, Richart C (2003) Bacteremia in adults due to glucose non-fermentative gram-negative bacilli other than P. aeruginosa. QJM 96:227–234PubMedCrossRef Vidal F, Mensa J, Almela M, Olona M, Martinez JA, Marco F, Lopez MJ, Soriano A, Horacajada JP, Gatell JM, Richart C (2003) Bacteremia in adults due to glucose non-fermentative gram-negative bacilli other than P. aeruginosa. QJM 96:227–234PubMedCrossRef
20.
go back to reference Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24:269–274PubMedCrossRef Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol 24:269–274PubMedCrossRef
21.
go back to reference Aisenberg G, Rolston K, Kontoyiannis DM, Raad I, Safdar A (2005) Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: matched case-control analysis in 44 individuals with low-risk of infection (1998–2004). In: Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract no. K-1535 Aisenberg G, Rolston K, Kontoyiannis DM, Raad I, Safdar A (2005) Stenotrophomonas maltophilia pneumonia (SmP) in 108 patients with cancer: matched case-control analysis in 44 individuals with low-risk of infection (1998–2004). In: Program and Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract no. K-1535
22.
go back to reference Cherif H, Kronvall G, Bjorkholm M, Kalin M (2003) Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4:420–426PubMedCrossRef Cherif H, Kronvall G, Bjorkholm M, Kalin M (2003) Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J 4:420–426PubMedCrossRef
23.
go back to reference Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed
24.
go back to reference Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34:1653–1656PubMedCrossRef Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR (2002) Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 34:1653–1656PubMedCrossRef
25.
go back to reference Raad I, Alrahwan A, Rolston K (1998) Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26:1182–1187PubMedCrossRef Raad I, Alrahwan A, Rolston K (1998) Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 26:1182–1187PubMedCrossRef
26.
go back to reference Micozzi A, Venditti M, Monaco M, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711PubMedCrossRef Micozzi A, Venditti M, Monaco M, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711PubMedCrossRef
27.
go back to reference Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteremia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumors. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef Martino R, Gomez L, Pericas R, Salazar R, Sola C, Sierra J, Garau J (2000) Bacteremia caused by non-glucose-fermenting gram-negative bacilli and Aeromonas species in patients with haematological malignancies and solid tumors. Eur J Clin Microbiol Infect Dis 19:320–323PubMedCrossRef
Metadata
Title
Changing trends in etiology of bacteremia in patients with cancer
Authors
A. Safdar
G. H. Rodriguez
M. Balakrishnan
J. J. Tarrand
K. V. I. Rolston
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2006
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0173-4

Other articles of this Issue 8/2006

European Journal of Clinical Microbiology & Infectious Diseases 8/2006 Go to the issue

Announcements

Announcements

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.